Roxithromycin in the eradication of Helicobacter pylori.
Goh
K L
KL
Chuah
S Y
SY
Azian
M
M
Parasakthi
N
N
Peh
S C
SC
Wong
N W
NW
Lo
Y L
YL
Ong
K K
KK
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D015575:Roxithromycin / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D009942:Organometallic Compounds; D010880:Piperidines; D015575:Roxithromycin; C002791:bismuth tripotassium dicitrate; D009853:Omeprazole; D001729:Bismuth; C053742:roxatidine acetate